Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new approach to alter the function of RNA in living cells by designing molecules that recognize and disable RNA targets. As a proof of principle, in the new study the team designed a molecule that disabled the RNA causing myotonic dystrophy.
Recent PostsSaturday, January 14, 2017
The University of South Florida College of Engineering and the USF Health Morsani College of Medicine have established the Department of Medical Engineering, a unique transdisciplinary concept that will combine the related aspects of engineering and medicine while providing access to real-world health care environments for education and research. ..Read More ⇒Thursday, January 12, 2017
Florida-based Flight Level Engineering has become the first company to join the Customized Business Acceleration Program at the John Mica Engineering and Aerospace Innovation Complex (MicaPlex) at Embry-Riddle Research Park in Daytona Beach. ..Read More ⇒Thursday, January 12, 2017
According to a 2015 report by the NIH’s National Institute on Aging, in the last five years of life, total health care spending for people with dementia was more than a quarter of a million dollars per person, 57 percent more than the costs associated with death from other diseases, including cancer and heart disease. ..Read More ⇒Thursday, January 12, 2017
Immunotherapy is a fast growing area of cancer research. It involves developing therapies that use a patient’s own immune system to fight and kill cancer. Moffitt Cancer Center is working on a new vaccine that would help early-stage breast cancer patients who have HER2 positive disease. ..Read More ⇒Wednesday, January 11, 2017
Graft-versus-host-disease (GVHD) is the leading cause of non-relapse associated death in patients who receive stem cell transplants. In a new study published as the cover story in Science Translational Medicine, Moffitt Cancer Center researchers show that a novel treatment can effectively inhibit the development of GVHD in mice and maintain the infection- and tumor-fighting capabilities of the immune system. ..Read More ⇒
Tagsphotonics University of Central Florida partnerships business magnets nanotechnology HIV/AIDS consumers cancer AxoGen society/culture Nova Southeastern Univ. conference / event University of Miami bioscience research policy Sanford-Burnham FL Institute for Commercialization of Public Research aging accreditation ecology AGTC biomedical green technology agriculture University of Florida marine Florida Trend Florida State University health Florida Gulf Coast Univ. energy Nanotheraputics accounting engineering University of West Florida aerospace health care biochemistry research physics economy BioFlorida materials science Florida Institute of Technology policy ICFO Draper Jackson Lab neuroscience Florida Atlantic University robotics awards FAMU Enterprise Florida Max Planck commercialization environment Mayo Clinic biotechnology education Univeristy of South Florida Florida Hospital sciences Banyan Biomarkers Florida International Univ. grants GrowFL medical accolades clean energy gender University of North Florida Moffitt Cancer Center computer science sustainability IHMC stem cell Torrey Pines Institute innovation VGTI Scripps Research Institute Embry-Riddle children technology animals Florida Power & Light astronomy